GILD vs OTGAW
Gilead Sciences Inc (GILD) versus OTG Acquisition Corp. I Warrants (OTGAW) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
OTG Acquisition Corp. I Warrants (OTGAW) common stock listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
OTGAW does not have a complete income-statement cache yet.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OTGAW currently screens at market cap $0.
Not investment advice. Open the GILD and OTGAW stock pages for the full models.
Not investment advice.